title: Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT.
authors.forename: S N
authors.initials: SN
authors.lastname: Singh
authors.forename: Q
authors.initials: Q
authors.lastname: Cao
authors.forename: I
authors.initials: I
authors.lastname: Gojo
authors.forename: A P
authors.initials: AP
authors.lastname: Rapoport
authors.forename: G
authors.initials: G
authors.lastname: Akpek
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077209:Decitabine; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000601:surgery; D017254:Leukemic Infiltration / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D033581:Stem Cell Transplantation / Q000379:methods*; D014184:Transplantation, Homologous
chemical_list: D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine
references.citation: Haematologica. 2010 Jun;95(6):860-3
references.pmid: 20513805
references.citation: Leuk Res. 2007 Feb;31(2):257-9
references.pmid: 16620971
references.citation: Cancer. 1999 Feb 1;85(3):608-15
references.pmid: 10091734
references.citation: Blood. 2008 Dec 1;112(12):4371-83
references.pmid: 19029455
references.citation: Cancer. 2009 May 1;115(9):1899-905
references.pmid: 19235255
references.citation: Blood. 2004 Mar 1;103(5):1635-40
references.pmid: 14604977
references.citation: Biol Blood Marrow Transplant. 2011 May;17(5):754-8
references.pmid: 20951817